Paras Healthcare Limited has launched its mainboard IPO, bringing one of India's growing hospital networks to the public market. Operating under the Paras Health brand, the company provides specialised healthcare services, including advanced medical treatment, critical care and complex surgical procedures.
The IPO opened for subscription on October 21, 2026, and will close on October 23. The company is looking to raise ₹1,450 crore through a combination of a ₹500 crore fresh issue and a ₹950 crore offer for sale by existing shareholders.
The IPO received a relatively modest response on its first day, with overall subscription reported at approximately 0.15 times. Retail investors showed comparatively stronger participation, while institutional demand had yet to gain momentum in the reported closing snapshot.
Investors are now monitoring the second-day subscription trend, grey market premium and the company's expansion plans as they evaluate the public offering.
Paras Healthcare IPO Details
| Particular | Details |
|---|---|
| Company Name | Paras Healthcare Limited |
| IPO Type | Mainboard IPO |
| IPO Open Date | October 21, 2026 |
| IPO Close Date | October 23, 2026 |
| Price Band | ₹660–₹693 |
| Face Value | ₹1 per share |
| Total Issue Size | ₹1,450 Crore |
| Fresh Issue | ₹500 Crore |
| Offer for Sale | ₹950 Crore |
| Lot Size | 21 Shares |
| Minimum Investment | ₹14,553 at upper price band |
| Listing Exchanges | BSE and NSE |
| Expected Allotment | October 26, 2026 |
| Expected Refund/Fund Unblocking | October 27, 2026 |
| Expected Demat Credit | October 27, 2026 |
| Expected Listing Date | October 28, 2026 |
| Registrar | MUFG Intime India |
| Lead Managers | JM Financial, BofA Securities India and Nuvama Wealth Management |
The fresh issue will provide capital to the company, while the OFS proceeds will go to the selling shareholders after applicable expenses.
Paras Healthcare IPO GMP Today
Paras Healthcare IPO's grey market premium has shown varying estimates across tracking platforms.
On October 21, reported GMP snapshots ranged from approximately ₹39 to ₹52 per share, depending on the source and reporting time.
| Particular | Details |
|---|---|
| Upper Price Band | ₹693 |
| Earlier Reported GMP Range | ₹39–₹52 |
| Indicative Listing Price | ₹732–₹745 |
| Indicative Premium | Approximately 5.63%–7.50% |
These figures are illustrative calculations based on earlier reported quotes and are not a verified live GMP for October 22, 2026.
The grey market premium is unofficial and may change during the IPO period. It does not guarantee the actual listing price or investor returns. Investors should avoid using GMP as the sole basis for an investment decision.
Paras Healthcare IPO Subscription Status
Paras Healthcare IPO recorded approximately 0.15 times overall subscription at the end of Day 1, according to reported subscription updates.
Retail investors led the initial demand, while institutional participation was relatively limited in the reported first-day figures.
| Investor Category | Day 1 Subscription |
|---|---|
| Overall | Approximately 0.15x |
| Retail Investors | Approximately 0.69x–0.73x |
| Non-Institutional Investors | Approximately 0.08x |
| Qualified Institutional Buyers | 0.00x in the reported snapshot |
The difference in retail subscription figures reflects varying reported snapshots. These are Day 1 figures, not the final subscription result.
Day 2 update: The issue is in its second day of bidding on October 22. Investors should check the latest NSE or BSE subscription figures for updated category-wise demand before publishing.
About Paras Healthcare Limited
Paras Healthcare Limited is a hospital operator offering tertiary and quaternary healthcare services through its Paras Health network.
As of June 30, 2026, the company operated eight hospitals with a combined capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar.
The company focuses on specialised treatment areas such as cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics and renal sciences.
Its business serves patients requiring advanced medical treatment and complex procedures. Hospital operations depend on medical expertise, infrastructure utilisation, treatment quality and the ability to attract patients and healthcare professionals.
Paras Healthcare Hospital Network and Expansion Plans
Paras Healthcare has been working to expand its hospital capacity and strengthen its presence in key healthcare markets.
The company's expansion plans include:
-
Gurugram hospital: A proposed 300-bed facility.
-
Ludhiana hospital: A planned 500-bed facility.
-
Capacity expansion: The company expects to increase its total bed capacity to 3,011 by March 2028, according to its offer-related disclosures.
Expansion could create additional revenue opportunities if the new hospitals achieve healthy occupancy levels and operating efficiency.
However, hospital development involves substantial investment, recruitment of medical professionals, equipment procurement and regulatory requirements. New facilities may also take time to reach sustainable profitability.
Paras Healthcare IPO Financial Performance
Paras Healthcare's financial performance should be evaluated through revenue growth, profitability, operating efficiency and debt levels.
The company reported revenue of approximately ₹1,605.95 crore and profit after tax of approximately ₹43.83 crore for the reported financial period referenced in earlier IPO coverage.
Its hospital occupancy rate showed improvement across the reported years.
| Particular | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Bed Occupancy Rate | 52.46% | 50.78% | 61.75% |
The improvement in occupancy during FY2026 may indicate better utilisation of the existing hospital infrastructure.
Nevertheless, occupancy is only one measure of performance. Investors should also review average revenue per occupied bed, operating margins, treatment mix, employee expenses and hospital-level profitability.
Financial figures should be cross-checked against the latest audited financial statements and Red Herring Prospectus before publication.
Paras Healthcare IPO Objectives
The company plans to utilise the net proceeds from the fresh issue primarily for debt repayment and general corporate purposes.
Key planned allocations include:
-
Debt repayment: Approximately ₹320.9 crore for repayment or prepayment of certain company borrowings.
-
Investment in subsidiary: Approximately ₹54.1 crore for investment in Plus Medicare Hospitals Private Limited to support repayment or prepayment of its borrowings.
-
General corporate purposes: The remaining eligible proceeds will be used for corporate requirements.
The planned debt reduction may improve financial flexibility and potentially reduce interest expenses.
However, healthcare businesses also require ongoing investment in infrastructure, medical equipment, staffing and expansion. The balance between debt reduction and future capital needs remains important.
Paras Healthcare IPO Anchor Investor Participation
Paras Healthcare raised approximately ₹652.5 crore through its anchor book ahead of the public issue.
The company reportedly allotted around 94.15 lakh equity shares to 21 institutional investors.
Anchor participation included global investors, domestic mutual funds and insurance companies.
Participation from institutional investors can provide information about pre-IPO demand, but anchor investments do not guarantee positive listing performance or future share-price appreciation.
Paras Healthcare IPO Growth Opportunities
Paras Healthcare operates in a sector where demand for specialised treatment and advanced medical infrastructure remains important.
Specialised healthcare services: Demand for complex procedures and specialised treatment may support patient volumes.
Hospital expansion: Additional facilities in Gurugram and Ludhiana could increase capacity and strengthen market presence.
Occupancy improvement: Better utilisation of hospital beds can support operating leverage if costs are managed effectively.
Regional healthcare demand: Its presence across multiple cities allows the company to serve different patient markets.
Advanced medical capabilities: Investment in clinical expertise and medical infrastructure may strengthen its competitive positioning.
These opportunities depend on patient demand, doctor retention, treatment quality, competition and efficient hospital management.
Risks of Investing in Paras Healthcare IPO
Investors should consider the following risks before applying:
-
Debt obligations: Borrowings can increase interest costs and put pressure on cash flow.
-
Expansion risk: New hospitals require significant capital and may take time to become profitable.
-
Hospital occupancy: Lower patient volumes can affect revenue while fixed operating costs continue.
-
Competition: Hospital operators compete for doctors, patients, insurance partnerships and specialised services.
-
Regulatory requirements: Healthcare operations face licensing, clinical and compliance obligations.
-
Medical staffing: Retaining experienced doctors and specialised healthcare professionals is essential.
-
Valuation risk: Investors should assess the issue valuation against earnings, growth prospects and listed hospital peers.
Reviewing the company's offer documents and risk factors is important before making an investment decision.
Paras Healthcare IPO Important Dates
| IPO Event | Date |
|---|---|
| Anchor Investor Bidding | October 19, 2026 |
| IPO Opens | October 21, 2026 |
| IPO Closes | October 23, 2026 |
| Basis of Allotment | October 26, 2026 |
| Refund/Fund Unblocking | October 27, 2026 |
| Shares Credited to Demat | October 27, 2026 |
| Expected Listing | October 28, 2026 |
The dates follow the announced schedule and may be subject to official exchange updates.
Paras Healthcare IPO: Key Takeaways
Paras Healthcare IPO is a ₹1,450 crore mainboard offering that provides exposure to India's specialised hospital sector. The company operates eight hospitals with 2,211 beds and has outlined plans to increase its capacity through upcoming hospital developments.
The IPO combines a fresh issue with an offer for sale, while a substantial portion of the fresh proceeds is intended for debt repayment and investment in its subsidiary.
The first-day subscription response was relatively muted, and the grey market premium estimates varied across sources. Investors should evaluate the company's hospital occupancy, debt position, expansion strategy, profitability and IPO valuation before making a decision.
The IPO closes on October 23, 2026, with listing expected on October 28. Updated subscription figures and verified market information should be checked before publication.
Loading comments...